Back to calendar
BioCryst Pharmaceuticals, Inc. (BCRX) Earnings
BCRX reports earnings on Wednesday, November 4, 2026
earnings report
November 4, 2026 · Before Market Open
Q3 2026
Est. EPS: $0.09
Actual EPS: $0.30
Company overview
Market Cap$2.5B
SectorHealth Technology
IndustryBiotechnology